Dose-response: Exercise Therapy on Hip Osteoarthritis

Osteoarthritis, Hip Clinical Trial

Official title:

Dose-response: Exercise Therapy on Hip Osteoarthritis, a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01700933
• Other study ID #: DROAPS1
• Status: Completed
• Phase: N/A
• First received: October 1, 2012
• Last updated: September 19, 2017
• Start date: September 2012
• Est. completion date: December 2014

Study information

• Verified date: September 2017
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Osteoarthritis is a common disease that causes muscle weakness, stiffness and instability. The disease reduces the opportunities for an active lifestyle. Exercise Therapy provides a well-documented effect on pain and function in patients with osteoarthritis of the hip. It is sought an optimal dose of exercise, in which this study will help to investigate.

We hypothesize that an exercise program designed to have a high number of repetitions will benefit the outcome of the training in a more positive way than a low-repetition based program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• At least three month since debut of the disease

• Age above 45 years

• Ability to complete the intervention

Exclusion Criteria:

• Pain above 4 on VAS during gait

• Pregnancy

• Autoimmune disease

• Cardiovascular disease

• Respiratory disease

• Metabolic disease

• Neurological signs

• Planned hip-replacement surgery within the next year

• Received exercise therapy within the last 3 months

Related Conditions & MeSH terms

• Osteoarthritis
• Osteoarthritis, Hip

Intervention

Other:
• High-Dosage Exercise Therapy
Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.)
• Low-Dosage Exercise Therapy
Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.)

Locations

Country	Name	City	State
Norway	Fysioterapitjenesten i Ørsta	Ørsta

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Østerås H, Paulsberg F, Olsen SE, Østerås B, Torstensen TA. Effects of medical exercise therapy in patients with hip osteoarthritis: A randomized controlled trial with six months follow-up. A pilot study. J Bodyw Mov Ther. 2017 Apr;21(2):284-289. doi: 10. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	WOMAC Index of Osteoarthritis (questionnaire)	WOMAC Index of Osteoarthritis (questionnaire)	0 weeks, 8 weeks, 6 months postinterventional
Secondary	HAD questionnaire		0 weeks, 8 weeks, 6 months postinterventional
Secondary	Tampa Scale for Kinesiophobia		0 weeks, 8 weeks, 6 months postinterventional
Secondary	Squats	Number of squats completed in 30 seconds.	0 weeks, 8 weeks, 6 months postinterventional
Secondary	Stairs	Time used to walk up and down 12 steps.	0 weeks, 8 weeks, 6 months postinterventional